Ceftazidime/Avibactam Resistance in Carbapenemase-Producing Klebsiella pneumoniae

Ceftazidime/Avibactam Resistance in Carbapenemase-Producing Klebsiella pneumoniae

We identified a novel ceftazidime/avibactam resistance mechanism in sequence type 11 Klebsiella pneumoniae carbapenemase 2–producing K. pneumoniae. Plasmid recombination and chromosomal integration formed a novel virulence plasmid and provided an additional promoter for blaSHV-12, leading to blaSHV...

Full description

Bibliographic Details
Main Authors:	Qiaozhen Cui, Chen Wang, Qichen Wang, Juanxiu Qin, Min Li, Baixing Ding, Zhen Shen
Format:	Article
Language:	English
Published:	Centers for Disease Control and Prevention 2023-11-01
Series:	Emerging Infectious Diseases
Online Access:	https://wwwnc.cdc.gov/eid/article/29/11/23-0830_article

Similar Items

Emergence of Ceftazidime- and Avibactam-Resistant Klebsiella pneumoniae Carbapenemase-Producing Pseudomonas aeruginosa in China
by: Yiwei Zhu, et al.
Published: (2021-12-01)

MIC profiling of ceftazidime/avibactam against two carbapenemase-producing Klebsiella pneumoniae isolates
by: Andrei Zidaru, et al.
Published: (2020-12-01)

In vitro and in vivo bactericidal activity of ceftazidime-avibactam against Carbapenemase–producing Klebsiella pneumoniae
by: Wenxia Zhang, et al.
Published: (2018-11-01)

Ceftazidime-avibactam based combinations against carbapenemase producing Klebsiella pneumoniae harboring hypervirulence plasmids
by: Zackery P. Bulman, et al.
Published: (2022-01-01)

Ca-EDTA restores the activity of ceftazidime-avibactam or aztreonam against carbapenemase-producing Klebsiella pneumoniae infections
by: Dhammika Leshan Wannigama, et al.
Published: (2023-07-01)

Carbapenemase-producing Klebsiella pneumoniae intra-abdominal infection successfully treated with ceftazidime/avibactam plus tigecycline
by: Mariana Guedes, et al.
Published: (2020-01-01)

Synergistic Effect of Ceftazidime-Avibactam with Aztreonam on Carbapenemase-Positive Klebsiella pneumoniae MBL+, NDM+
by: Szymański M, et al.
Published: (2024-06-01)

Prosthetic Joint Infection from Carbapenemase-Resistant Klebsiella pneumoniae Successfully Treated with Ceftazidime-Avibactam
by: A. Schimmenti, et al.
Published: (2018-01-01)

In vitro Optimization of Ceftazidime/Avibactam for KPC-Producing Klebsiella pneumoniae
by: Yanqin Huang, et al.
Published: (2021-03-01)

Review of In Vitro Efficacy of Ceftazidime-Avibactam, Meropenem-Vaborbactam and Imipenem-Relebactam in Carbapenemase Producing Klebsiella pneumoniae Isolates
by: Özlem AYDEMİR, et al.
Published: (2023-09-01)

Ceftazidime-avibactam in urinary tract infections due to carbapenemase-producing Klebsiella in kidney transplantation
by: Fernando Caravaca-Fontán, et al.
Published: (2015-07-01)

Ceftazidime-avibactam resistance in KPC-producing Klebsiella pneumoniae accompanied hypermucoviscosity acquisition
by: Yingyi Guo, et al.
Published: (2024-10-01)

Synergistic Effect of Ceftazidime-Avibactam with Aztreonam on Carbapenemase-Positive Klebsiella pneumoniae MBL+, NDM+ [Letter]
by: Pathak KN, et al.
Published: (2024-07-01)

Evaluation of In Vitro Activity of Ceftolozane-tazobactam and Ceftazidime-avibactam Against Carbapenemase-producing Multi-drug Resistant Klebsiella pneumoniae Isolates
by: Hüseyin Agah TERZİ, et al.
Published: (2020-12-01)

Synergy between Mecillinam and Ceftazidime/Avibactam or Avibactam against Multi-Drug-Resistant Carbapenemase-Producing <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i>
by: Karoline Knudsen List, et al.
Published: (2022-09-01)

Synergistic Effect of Ceftazidime-Avibactam with Aztreonam on Carbapenemase-Positive Klebsiella pneumoniae MBL+, NDM+ [Response to Letter]
by: Szymański M, et al.
Published: (2024-07-01)

The <i>Klebsiella pneumoniae</i> carbapenemase (KPC) β-Lactamase Has Evolved in Response to Ceftazidime Avibactam
by: Sona Garsevanyan, et al.
Published: (2023-12-01)

Ceftazidime–Avibactam Improves Outcomes in High-Risk Neutropenic Patients with <i>Klebsiella pneumoniae</i> Carbapenemase-Producing Enterobacterales Bacteremia
by: Fabián Herrera, et al.
Published: (2024-01-01)

Loss and gain of ceftazidime-avibactam susceptibility in a non-carbapenemase-producing K1-ST23 hypervirulent Klebsiella pneumoniae
by: Jiankang Zhao, et al.
Published: (2024-12-01)

In vitro antibacterial activity of ceftazidime/avibactam in combination against planktonic and biofilm carbapenemase-producing Klebsiella pneumoniae isolated from blood
by: Chiara Papalini, et al.
Published: (2020-12-01)

Community-acquired bacteraemia by Klebsiella pneumoniae producing KPC-3 and resistant to ceftazidime/avibactam
by: Isabel Machuca, et al.
Published: (2022-09-01)

Reduced Ceftazidime-Avibactam Susceptibility in KPC-Producing Klebsiella pneumoniae From Patients Without Ceftazidime-Avibactam Use History – A Multicenter Study in China
by: Xiaoyan Cui, et al.
Published: (2020-06-01)

In vitro effectiveness of ceftazidime-avibactam in combination with aztreonam on carbapenemase-producing Enterobacterales
by: Papa-Ezdra Romina, et al.
Published: (2023-12-01)

74: TREATING CARBAPENEMASE-PRODUCING ENTEROBACTERALES UROSEPSIS WITH CEFTAZIDIME/AVIBACTAM IN PREGNANCY
by: C. Kendrick, et al.
Published: (2022-11-01)

Ceftazidime-avibactam in the treatment of infections from carbapenem-resistant Klebsiella pneumoniae
by: Jie Gu, et al.
Published: (2021-09-01)

Ceftazidime-avibactam susceptibility against Escherichia coli and Klebsiella pneumoniae
by: Arun Sachu, et al.
Published: (2025-02-01)

In Vitro Evaluation of Increasing Avibactam Concentrations on Ceftazidime Activity against Ceftazidime/Avibactam-Susceptible and Resistant KPC-Producing <i>Klebsiella pneumoniae</i> Clinical Isolates
by: Marta Palombo, et al.
Published: (2023-12-01)

Ceftazidim-avibactam susceptibility of carbapenemase producing enterobacterales in an OXA-48 endemic area
by: Şevval Arduç Tok, et al.
Published: (2024-12-01)

Diversity of Ceftazidime-Avibactam Resistance Mechanism in KPC2-Producing Klebsiella pneumoniae Under Antibiotic Selection Pressure
by: Jiang M, et al.
Published: (2022-08-01)

In Vitro Efficacy of Ceftazidime-avibactam Against blaOXA-48-producing Klebsiella pneumoniae Isolates
by: Yasemin ÇAĞ, et al.
Published: (2023-11-01)

Ceftazidime-avibactam: Combination therapy versus monotherapy in the challenge of pneumonia caused by carbapenem-resistant Klebsiella pneumoniae
by: Chang-wei Liu, et al.
Published: (2024-08-01)

Ceftazidime/Avibactam-Resistant <i>Klebsiella pneumoniae</i> subsp. <i>pneumoniae</i> Isolates in a Tertiary Italian Hospital: Identification of a New Mutation of the Carbapenemase Type 3 (KPC-3) Gene Conferring Ceftazidime/Avibactam Resistance
by: Carla Fontana, et al.
Published: (2021-11-01)

Ceftazidime–Avibactam in Combination with Imipenem as Salvage Therapy for ST11 KPC-33-Producing <i>Klebsiella pneumoniae</i>
by: Li Ding, et al.
Published: (2022-04-01)

Pharmacokinetic/pharmacodynamic modelling to evaluate the efficacy of various dosing regimens of ceftazidime/avibactam in patients with pneumonia caused by Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae: a multicentre study in northern China
by: Yixin Kang, et al.
Published: (2021-12-01)

Efficacy of Ceftazidime-Avibactam in the Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infection After Kidney Transplantation
by: Zhang F, et al.
Published: (2021-12-01)

In Vitro Activity of Ceftolozane/tazobactam and Ceftazidime/avibactam Against Carbapenemase-producing Pseudomonas aeruginosa
by: Özlem AYDEMİR, et al.
Published: (2019-12-01)

Identification of KPC-112 from an ST15 Klebsiella pneumoniae Strain Conferring Resistance to Ceftazidime-Avibactam
by: Siquan Shen, et al.
Published: (2022-12-01)

Effect of ceftazidime-avibactam combined with different antimicrobials against carbapenem-resistant Klebsiella pneumoniae
by: Yun Wu, et al.
Published: (2024-06-01)

Cure of recurring Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae septic shock episodes due to complicated soft tissue infection using a ceftazidime and avibactam-based regimen: a case report
by: Giustino Parruti, et al.
Published: (2019-01-01)

Overexpression of KPC contributes to ceftazidime-avibactam heteroresistance in clinical isolates of carbapenem-resistant Klebsiella pneumoniae
by: Yitan Li, et al.
Published: (2024-12-01)